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Digital technologies and data science have laid down the promise to revolutionize
healthcare by transforming the way health and disease are analyzed and managed in
the future. Digital health applications in healthcare include telemedicine, electronic health
records, wearable, implantable, injectable and ingestible digital medical devices, health
mobile apps as well as the application of artificial intelligence and machine learning
algorithms to medical and public health prognosis and decision-making. As is often the
case with technological advancement, progress in digital health raises compelling ethical,
legal, and social implications (ELSI). This article aims to succinctly map relevant ELSI of
the digital health field. The issues of patient autonomy; assessment, value attribution,
and validation of health innovation; equity and trustworthiness in healthcare; professional
roles and skills and data protection and security are highlighted against the backdrop
of the risks of dehumanization of care, the limitations of machine learning-based
decision-making and, ultimately, the future contours of human interaction in medicine
and public health. The running theme to this article is the underlying tension between the
promises of digital health and its many challenges, which is heightened by the contrasting
pace of scientific progress and the timed responses provided by law and ethics. Digital
applications can prove to be valuable allies for human skills in medicine and public health.
Similarly, ethics and the law can be interpreted and perceived as more than obstacles,
but also promoters of fairness, inclusiveness, creativity and innovation in health.
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INTRODUCTION
Innovative solutions to both classic and emergent medical problems have resulted from the impact
of the digital revolution on healthcare (1, 2). Prominent examples include telemedicine, electronic
health records, wearable, implantable, injectable and ingestible medical devices, healthmobile apps,
and the application of artificial intelligence (AI) algorithms to health settings (3). Correspondingly,
computer power, interconnectivity and storage capacity, have potentiated the collection, analysis,
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and sharing of health data. These advancements, coupled with
the expansion of data generation capabilities have led to an era
of big data in healthcare, which promises to facilitate timely
and precise healthcare interventions (4, 5). In order to achieve
this aim, the extraction of knowledge from big data through the
interdisciplinary work of data science is fundamental (6).
Better healthcare quality as a result of digital health
applications and data science methods is an appealing
promise, which also elicits significant ethical, legal, and
social challenges (Table 1). This article aims to outline this
dichotomy, with a limited focus on the examples of telemedicine
and AI, which are two specific and interconnected areas
in expansion.
In broad terms, telemedicine and telehealth consist
in the practice of healthcare through information and
telecommunication systems (7). This branch of digital health
has had notorious growth in the last years and particularly
during the COVID-19 pandemic (8–10). Its applications include,
but are not restricted to, real-time health consultations from a
distance, remote health data collection, analysis, interpretation,
and monitoring, and digital interactions with health assistants,
including virtual ones (7). Accordingly, these subjects have
deserved particular ethical, legal and scholar attention in recent
years (7, 11–13).
In parallel, AI applications in healthcare have gathered
significant interest (14, 15). These include, but are also
not restricted to, analysis of health data to predict health
events and outcomes, check symptoms and improve diagnosis,
suggest preventive strategies, design and develop new medicines,
improve the organization and conduction of clinical trials,
enhance patient experiences, and advance the structure and
intelligibility of electronic health records (5, 14, 16–19).
Consequently, the influence of AI and machine learning in
the health sector is projected to expand and affect the work
of healthcare professionals, the efficiency of health systems,
and the capacity of patients to interpret their own health data
(18, 20, 21). Similarly, awareness about the ethical, legal and
social dimensions of AI broadened (22–25), which will hopefully
translate into better regulation (26–28).
With a balanced view between promises and challenges and
telemedicine and AI as examples, this article aims to provide a
succinct review of the main ethical, legal and social implications
(ELSI) of the adoption of digital technologies and the processing
of health data in medicine and public health.
METHODS
The main topics highlighted in this article resulted from an
initial literature search using electronic platforms PubMed and
Google Scholar and general search terms (corresponding to
the article keywords in combination with “ethics,” “law,” and
“ELSI”). Additional references were identified by backward
and forward citation chaining. Finally, articles from scholars
known to the author were also analyzed to complement
the analysis.
ELSI OF THE ADOPTION OF DIGITAL
TECHNOLOGIES IN HEALTHCARE
Trust, Quality, and the Doctor–Patient
Relationship
Trust is a fundamental and reciprocal value in healthcare. To
obtain guidance and care, patients trust health professionals
in a context of asymmetrical information (29). Conversely,
health professionals trust patients to describe their individual
experience and their medical history, as well as adhering to
recommended behaviors and treatments (30). Therefore, the
doctor–patient relationship is based on mutual trust, which is
fundamental to ensure quality of care (31, 32). Admittedly,
the uptake of digital technologies in healthcare can affect the
doctor–patient relationship by reducing human contact and
proximity (33). This effect has been substantially debated in
the context of telemedicine (9, 12, 34, 35). In particular, the
possible devaluation of the importance of continuous face-
to-face interactions between patients and doctors, of non-
verbal cues and of established ways of building empathy
and rapport for economical or efficiency reasons have been
highlighted (9). Notably, the impact of digital technologies
(and telemedicine in particular) on the doctor-relationship
might be very different depending on medical specialty. For
example, it might be low for some interactions in dermatology,
and completely reshape relations in the context of mental
health specialties (35). Likewise, specific functions (image
analysis/evaluation of health parameters vs. communication of
diagnosis, for example) might also be impacted differently. These
considerations reinforce the need to value patient context and
preferences in order to improve quality in health, as superficial
relationships (even if quantitatively informed) might lead to
superficial care.
In a context of increased reliance on digital technologies,
the trustworthiness of digital services and goods is fundamental
to preserve the value of trust, to strengthen the doctor–
patient relationship and increase healthcare quality (36).
To achieve these goals, it is essential to rigorously assess
the analytical validity and clinical validity and utility of
digital technologies (37, 38). Particularly, validity assessment
must consider scientific standards for market clearance and
authorization, licensing and periodical evaluation, definition
and enforceability of quality control norms, and professional
requirements for usage and operation (including training,
registration and authentication rules). However, despite ongoing
efforts, audit and certification procedures are often variable,
opaque and incompatible with the rhythm of technological
progress (37, 39–41). Furthermore, clinical utility must be
critically estimated and, subsequently, communicated to users,
which involves the capacity to properly perceive and transmit
technology’s benefits and risks, as well as uncertain notions
such as probability and variance. These issues, together with
legal liability clarification and definition of malpractice norms
across different geographies and jurisdictions, have been clearly
identified as fundamental to guarantee that quality of care and
patient safety are protected and hopefully improved during
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a sharp uptake of telemedicine and telehealth (8, 9, 34,
35).
Different health stakeholders will deliberate and define
relations of trust differently (42). Nonetheless, in broad terms,
the recommendation or adoption of subpar digital health services
and products risks fostering mistrust in healthcare professionals,
institutions and systems, which might ultimately affect the whole
digital health field and the broader scientific endeavor (43, 44).
As an example, paradigm cases like Theranos, in which a hyped
promise to revolutionize the blood tests industry turned out to
be fraudulent, illustrate the damage that can result from the lack
of adequate scrutiny (45). Digital health has lessons to learn from
this and other similar cases. Ultimately, the implementation of
rigorous, updated and intelligible assessment models is a key
component of the digital health promise to promote and advance
ethics, evidence, and value-based healthcare (46).
In particular, the introduction of AI and machine learning
algorithms in healthcare provides a relevant illustration of
the growing need for dedicated assessment and validation.
Although progress in the area of deep neural networks allows
for assessment of algorithmic capacity using synthetic data,
including medical images (47), peer-reviewed real-world clinical
data must not be abandoned if poor accuracy or undetermined
clinical utility are to be avoided (18). Cases like the IBM
Watson-mediated promotion of unsafe and incorrect treatment
recommendations to hospitals and medical doctors globally,
illustrate how risky it is to adopt AI-based approaches without
proper validation, particularly as these flaws can potentially affect
large numbers of patients in a short timespan, severely affecting
the elements of trust and quality in healthcare (48).
Finally, the extreme case of superficiality in contemporary
and future medicine, some argue, is machinal healthcare (33).
In fact, it might be precisely in healthcare that dehumanization
might prove more costly as human vulnerability, hope, suffering,
dependence and, ultimately, death are at stake (49). In
accordance, healthcare practice extends beyond technical analysis
to include ethics and morality. Interestingly, the competence of
machines for moral reasoning, judgement and decision-making
is a developing discussion (50–52). Either way, it would reinforce
trust, promote quality and strengthen the doctor patient-
relationship if digital health tools, and AI in particular, provide
stronger incentives for healthcare professionals to focus on
caring, compassion, and communication. These are fundamental
skills, which are perceived by patients to be in decline (33, 53).
Transparency, Bias, and Exclusion
In order to achieve its highest aims while preserving trust, the
uptake of digital technologies in healthcare must be transparent
(40). In a world where data can be artificially created, it
is increasingly important that the non-human dimensions of
healthcare are disclosed, including the usage of models and
algorithms, both in and outside the context of telehealth (9,
14, 15, 54). Therefore, medical decisions supported by digital
technologies should be more transparent and understandable,
in order to simultaneously guarantee accountability and avoid
patient disenfranchizement and exclusion. For example, the
TABLE 1 | Summary of relevant ethical, legal, and social issues (ELSI) raised by
digital technologies and health data processing in healthcare.
Digital health ELSI
Ethical
• Promotion of patient autonomy and empowerment
• Design, obtainment, and interpretation informed consent
• Identity confirmation and authentication
• Achieving fair distribution of risks, benefits, and costs
• Guaranteeing quality of care
• Strengthening the doctor–patient relationship
• Assuring continuity of care
• Defining professional duties and responsibilities
• Maintaining confidentiality
• Patient-generated health data
• Direct to consumer telemedicine and unsolicited requests for diagnosis and
individual health management
• Dehumanization of care
• Moral status and ethical judgement of machines
• Human nature, quantified-self and technological singularity
Legal
• Appropriateness, coherence, and accessibility of regulation, including
inconsistencies in interpretation by oversight bodies
• Assessment of validity, utility and quality of products, services, strategies,
and interventions
• Data protection rights (including privacy by default, privacy by design, data
destruction policies, the right to know and the right not to know)
• Data access, return of information and non-discrimination
• Data ownership rights, fair, transparent, and harmonized data sharing rules
• Compliance standards, oversight, and sanctions
• Broader data and device security issues
• Jurisdiction and licensure for telemedicine
Social
• Level of public participation and awareness
• Digital literacy levels of patients and health professionals
• Academic curricula adequacy (upgrades and updates)
• Limits to privacy and confidentiality in health
• Inequality and social stigma
• Lifestyle changes and adoption of healthy behaviors
• Impact on health access (economic, geographical, and informational)
Despite categorization, issues are mainly hybrid in nature.
incapacity to understand and scrutinize algorithm decision-
making leading to less transparency, a challenge known as
the black box problem, is currently subject to intense debate
including in the healthcare context (55, 56). Notably, the “right to
explanation” of algorithm decisions and requirements for human
intervention are legally established in different jurisdictions
(57). In contrast, some authors view a degree of uncertainty as
inevitable and perceive these conditions as obstacles to progress
(18, 58). Nonetheless, common ground can be found in the
need for better integration of scientific disciplines to surpass
hyper technical discussions (and limited understanding and
explainability) in contemporary medicine in the context of digital
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health in general, and AI in particular. Consequently, adaptation
of academic curricula to digital health developments should be
prioritized (59). In parallel, the emergence of new health skills or
professions that oversee the development of common languages,
intersect different disciplines, assist in science implementation
and facilitate interactions between different stakeholders is
likely (60).
On a separate yet related note, flawed algorithms can
feed into human bias and potentiate discrimination (61, 62).
Moreover, as the widespread use of facial recognition technology
(FRT) edges closer, questionable studies portraying facial traits
as proxies for different characteristics (including economic
condition, emotional status, and sexual orientation) multiply,
raising justified concerns about bias (63–65). The same is
true for extrapolating conclusions from online digital behavior
(66, 67). Healthcare is not foreign to this debate as FRT
can be used to diagnose medical and genetic conditions, for
example (68). Notoriously, the issue of AI bias is still open
and evolving (69, 70). Nonetheless, it is unreasonable to expect
that simply dehumanizing the flawed dimensions of healthcare
will per se facilitate fairer health outcomes. Expectedly, feeding
AI with biased data will lead to biased and unjust decisions
(71, 72). Hence, AI implementation in healthcare demands great
responsibility (73, 74). Additionally, data is context-dependent
and biased context can result in biased conclusions, as studies
have shown (75). Conversely, decontextualization of data can
also result in algorithm bias, flawed decisions, and discrimination
(75, 76). These are renewed arguments to keep fairness and justice
at the center of the healthcare debate.
ELSI OF DIGITAL HEALTH DATA
PROCESSING
Autonomy, Consent, and Patient
Participation
Grounded on the principle of autonomy, informed consent is a
cornerstone of medical ethics. Valid informed consent requires
a clear and precise acknowledgement of the situation, freedom
from coercion (physical or psychological), and competence for
decision making (or representation, in the case of minors
and incompetent adults) (77). Notably, guaranteeing informed
consent for heath research or care purposes, faces singular
challenges in the digital era, including identity confirmation,
remote evaluation of voluntariness, assessment of understanding
levels and competence determination (78, 79).
Defining the scope of consent for health data processing
is especially difficult. On one hand, single purpose consent is
problematic as secondary uses are often necessary for research
and care purposes and re-consent is impracticable (80). On the
other hand, in an increasingly fluid ecosystem with expanding
interactions between different stakeholders and infrastructures
(hospitals, clinics, biobanks, research institutes, biotechnology,
and pharma) and possible cycling of health data between
health research and healthcare contexts, significant challenges
are posed to classical informed consent models. Consequently, in
alternative to otherwise open consent options, dynamic consent
models have been proposed and justify continuous efforts of
implementation (81, 82). Additionally, as health data anonymity
is a commodity in an interconnected digital context, legal
compliance, management of expectations and risk assessment
and communication add extra pressure and complexity to the
informed consent process (83–85). Furthermore, some types of
health data (for example genetic data), might be shared by more
than one person, blurring the limits of individual consent and
rights while urging extra care in defining norms and interpreting
the law (86).
Along with these challenges to informed consent, the
issues of patient autonomy, participation and the doctor–
patient relationship converge on other equally challenging digital
health data trends. For example, health data can now be
generated by patients themselves (via apps, wearables, and
other digital means) (87). In parallel, healthcare interactions
can be patient-initiated (requests of diagnosis and treatment,
for example) (88). Thirdly, direct-to-consumer health services,
including telemedicine and AI, are expanding (17, 89). These
trends highlight the need to extract meaning and knowledge
from large quantities of data, while protecting patients from
misinformation, misjudgement and disenfranchizement (90).
For example, individual and collective risks such as unjustified
anxiety, false reassurance and overconsumption of scarce health
resources are magnified by digital health illiteracy, neglect,
or abandonment to excessive technicality (15, 17, 87, 91).
Equally, confirming the accuracy of patient-generated health
data and streamlining its integration with electronic health
records should be harmonized if healthcare quality is to be
promoted (92).
It is well-established that health illiteracy and the digital
divide affect patient participation, possibly compromising access
to healthcare (93–96). Therefore, to respect autonomy and
promote patient participation, the most vulnerable (due to
isolation, disability, age, illiteracy, and other factors) deserve
special attention and protection. This implies rejecting a one-size-
fits-all approach and tailoring digital healthcare encounters to
individual needs and histories, which are told by different types
of data. Among different digital health services and products,
which can promote health data sharing and healthcare access,
telemedicine has understandably gathered special recognition
due to its proven capacity to extend healthcare access to
isolated communities (35, 97). Nonetheless, challenges remain
as some studies have also indicated that telemedicine services
might contribute to medicalize the home context and end
up worsening isolation and dependence in some cases (35).
This fact further underlines the relevance of context-dependent
assessment models and implementation efforts. Furthermore,
as telehealth services grew quickly to meet demand in a
context of reduced physical interactions such as the COVID-
19 pandemic, one must not use the lack of immediate
alternatives as an excuse for neglecting fundamental aspects of
healthcare ethics. Particularly, the delimitation of professional
responsibilities (clinical, administrative, and other) related
with health data accessibility and sharing [including the
clarification of End User License Agreements (EULAs)] and
improved risk communication and cultural respect in digital
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interactions must be focused on in order to attribute real
meaning to health data and achieve the highest hopes for this
technology (9).
Finally, it is the human pondering of different alternatives that
enriches the consent process and furthers patient participation
and autonomy in healthcare. As machine learning algorithms
gather more influence and prove to be increasingly autonomous,
new challenges are posed to these ethical principles in the context
of health data processing (98). Therefore, progress in healthcare
should not consist in the promotion of machine autonomy at the
expense of human autonomy. On the contrary, well-established
human values in healthcare, such as integrity, conscientiousness
and compassion must guide health data processing in a digital
context and work as allies of digital health innovation.
Privacy, Confidentiality, and Security
The issues of privacy, confidentiality and data protection are
recognized as fundamental rights in most jurisdictions and
are especially challenging for digital health (99–103). The old
debate surrounding the erosion of privacy and confidentiality in
health settings endures (104, 105). For example, the protection
of electronic health records has been widely recognized as
insufficient (106, 107). Furthermore, privacy protection, data
access, interoperability, and quality of recorded data are
recurrently reported as ELSI of digital health, including of
telemedicine (9, 12, 34, 35). Undoubtedly, health data processing
is essential for medical and scientific progress and should follow
transparent, balanced and fair rules (108–112). In order to
strengthen fundamental rights in the digital age and regulate
the free movement of personal data, including health data,
the EU has adopted the General Data Protection Regulation
(GDPR) (113). This broad ranging legal document reinforced
mechanisms of data protection, includingmore transparency and
accountability, mandatory impact assessments, pan-European
validation of codes of conduct, certification procedures, and
more severe sanctions (114). Furthermore, rights of data subjects
were enhanced, including a right of access and rights to
information, explanation, rectification, erasure, restriction of
processing, data portability, object and not to be subject to
automated individual decision-making (113). Due to its broad
scope and recent nature, it is still early to judge the impact
of GDPR in the health area. Additionally, harmonization of
health data flows across jurisdictions is still problematic. For
example, the successive European Court of Justice Schrems cases
(115), leading to successive annulments of legal agreements
regulating EU-US data flows, have impacted health research and
healthcare (116).
In parallel, health data security has become a serious
concern as poor protection measures combined with high
transactional value, exacerbate the risk of violations and damages
(117, 118). Particular cybersecurity concerns emerge from the
expansion of digital health, including telemedicine and the
multiplication of interconnected sensors and medical devices
(119), which has rightly deserved regulatory attention (120–123).
Ultimately, healthcare institutions should see their data security
infrastructure strengthened and recent technological progress
can provide the tools for risk mitigation (124).
In complement to data protection measures, responsible use
of data is key. Especially, projects with public notoriety demand
greater responsibility if public trust is to be preserved. For
example, cases such as the Google Deepmind collaboration
with the UK NHS (125, 126), NHS England’s care.data
programme (127), or “Project Nightingale” in the US, in
which patient data was accessed by commercial companies
without informed consent, emphasize the need for transparency,
communication and responsibility in order to guarantee the
positive impact of data sharing on healthcare. In contrast,
opacity extends power imbalances and unprotects citizens
(128). Therefore, clear and fair health data ownership rules,
beyond the traditional property approaches, should continue
to be developed and harmonized. These should guarantee
patient access to their data (129) while limiting access and
usage by third parties without a compelling interest. Moreover,
different strategies can be adopted to encourage responsible
use of health data. For example, investing in healthcare ethics
literacy programs, implementing validated codes of conduct
(institutional, national, and international), refining deontology
rules (for health professionals and data scientists), protecting
whistleblowers of data mistreatment practices, setting fair
procedures, and imposing dissuasive sanctions (disciplinary,
legal, and social) for confirmed misconduct. Obviously, such
strategies must include electronic health records and health data
shared in telemedicine settings, processed by mobile apps and
medical devices, as well as AI algorithms (130, 131).
DISCUSSION
The digital revolution has impacted different areas of society,
including healthcare (19). At the core of this transformation
is an increased capacity to process large quantities of health
data using digital means (15, 16). Big data in healthcare
originates from different sources, including biological and social
determinants, health records, environmental signals, habits, and
behaviors (19, 132, 133). Against this backdrop, telemedicine
and telehealth services expanded significantly in recent years,
particularly during the COVID-19 pandemic (10). Furthermore,
AI applications are gaining ground in complementing even
the most knowledgeable or skilled professionals (134, 135).
Concomitantly, a new era of precision healthcare is promised,
where the right individual and public intervention is available for
the right patient or population at the right time (136–141).
In this context, the optimization of health data processing
using digital means and the general uptake of digital technologies
can rightly be perceived as health enablers. In parallel, compelling
related ELSI must be considered and dealt with.
Expectedly, healthier activities and wiser health choices
should result from better data science. In this sense, digitally-
mediated health data processing can promote individual
autonomy and patient empowerment (142–144). However, the
adoption of healthy behaviors does not emerge linearly from
better health information (which must be extracted from health
data) as human decision making is complex and affected by
context and cognitive biases, combining emotion and reason.
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Therefore, data-assisted decision making in healthcare, justifies
a closer collaboration between healthcare professionals, decision,
and data scientists and ethicists (15, 33). In fact, the links between
health data and statistics literacy and healthcare quality is a
classical debate, which is expected to intensify (145). Indeed, the
adoption of digital technologies has the potential to improve the
volume and quality of health data processing in order to expand
knowledge to professionals and patients alike. However, a lack of
common platforms and cross-disciplinary languages to deal with
increasing technical complexity are significant challenges (146).
Also, can technology, data and analytical models alone capture
human vulnerability, suffering, fears, hopes and potential?
Evidently not. Nonetheless, these can elevate the standard
of care by providing healthcare professionals with invaluable
(an otherwise inaccessible) information and knowledge, while
alleviating the burden of repetitive and laborious tasks to focus
on compassion and emotional connections, which are associated
with the highest quality (15, 33). To this end, patient stories,
particularly those of the most vulnerable, must be heard and
understood and one must be mindful that health data misuse can
contribute to misinformation, poorer care, reinforced exclusion
or stigmatization. Notably, such risks are exacerbated if human
health and disease are looked at from a purely quantitative
lens (147–150). There is, however, cause for optimism as digital
technologies can also be used to promote scientific robustness
and tackle the very risks it potentially generates (151–154).
Balanced health data processing and usage of digital
technologies to improve healthcare quality is a matter of
public interest. Presently, there is significant data access
asymmetries between citizens, corporations and governments
(128). Therefore, urgent efforts are necessary to reach an inclusive
and democratic deliberation leading to the simultaneous
advancement of science and human rights. Importantly, digital
technologies can advance the fulfillment of the human right
to health. Specifically, they can improve the availability of
health facilities, services and goods; increase the acceptability of
practices (by incorporating medical ethics and approximating
cultures); raise the quality of scientific and medical services,
goods and professional skills; and promote access without
discrimination (155, 156). The specific issue of fairness regarding
access to digital technologies has been a key topic in the context
of the accelerated uptake of telemedicine. This is particularly
relevant as those who are more likely to benefit from this
technology and its applications (isolated communities, including
in rural areas) are also those who, predictably, are less capable of
affording or using them (35). Therefore, public and individual
interests must be properly balanced in order to maximize the
potential of this technology while respecting human rights.
Additionally, big data, telehealth, machine learning algorithms
and the era of individual profiling might be ingredients for
deeper discrimination and stigmatization (142). In summary, the
positive application of digital technologies and data science in
medicine and public health should promote, not defer progress
in social justice.
In conclusion, the ELSI of the digital health field (Table 1)
are compelling and proportional to the positive impact of digital
technologies in healthcare. Consequently, normative orders such
as law and ethics should act as beneficial limit-setters and
promoters of just, creative and innovative realities. Accordingly,
digital health ELSI convoke ethicists, legal scholars, patients,
scientists, health professionals, health providers and payers,
regulators, managers, and other decision makers to play a role
in this fascinating field, which promises to decisively shape the
way health and disease are perceived, assessed and managed in
the future (157, 158).
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